ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Apoptosis"

  • Abstract Number: 2296 • 2012 ACR/ARHP Annual Meeting

    Platelet Release Products Mediate Endothelial Apoptosis: A Possible Role for Thrombospondin 1- CD36 Pathway in SSc-Endothelial Apoptosis

    Bashar Kahaleh1 and Yongqing Wang2, 1Medicine/Rheumatology, University of Toledo, Toledo, OH, 2Medicine, University of Toledo, Toledo, OH

    Background/Purpose: Sequential pathologic observations in the early stages of SSc demonstrated evidence for platelet aggregation and binding to blood vessels that is generally followed by…
  • Abstract Number: 2083 • 2012 ACR/ARHP Annual Meeting

    New Treatment Approach of Rheumatoid Arthritis Based On Inhibition of Cyclin Dependent Kinase-9

    Annelie Hellvard1, Lutz Zeitlmann2, Ulrich Heiser3, André Niestroj3, Hans-Ulrich Demuth3, Jan Potempa4 and Piotr Mydel1, 1Broegelmann Research Laboratory, The Gade Institute, University of Bergen, Bergen, Norway, 2Ingenium Pharmaceuticals GmbH, Martinsried, Germany, 3Probiodrug AG, Halle/Saale, Germany, 4Microbiology Department, Jagiellonian University, Krakow, Poland

    Background/Purpose: Cyclin dependent kinase-9 (cdk-9) is transcription regulator of the carboxyterminal domain of RNA polymerase II. The usage of pan-cdk inhibitors such as flavopiridol has…
  • Abstract Number: 1782 • 2012 ACR/ARHP Annual Meeting

    Dual Effects of Soluble FasL and Membrane Bound FasL On Fibroblast-Like Synoviocytes Cells (FLS) From Rheumatoid Arthritis (RA) Patients

    Rachel Audo1, Flavia Calmon-Hamaty1, Bernard Combe2, Michael Hahne1 and Jacques Morel3, 1IGMM, CNRS UMR5535, Montpellier, Montpellier, France, 2Rheumatology, Hopital Lapeyronie, Montpellier, France, 3Dpartment of Rheumatology, Lapeyronie Hospital, Montpellier, France

    Background/Purpose: Membrane bound FasL (mFasL) is able to induce fibroblast-like synoviocytes (FLS) cell death. In experimental arthritis mouse models, injection of agonistic antibody  (Ab) anti-Fas…
  • Abstract Number: 1776 • 2012 ACR/ARHP Annual Meeting

    Anti-SSA/Ro Mediated Injury to the Endothelium Via Urokinase Plasminogen Activator Receptor/Tgfbeta Activation: Implications in the Pathogenesis of Congenital Heart Block

    Paraskevi Briasouli1, Mark Halushka2, Jill P. Buyon3 and Robert M. Clancy4, 1Rheumatology, New York University Medical Center, New York, NY, 2Division of Cardiovascular Pathology, John Hopkins Pathology, Baltimore, MD, 3Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 4Medicine, New York University School of Medicine, New York, NY

    Background/Purpose: One mechanism by which anti-Ro antibodies are linked to the pathogenesis of (cardiac-NL) neonatal lupus is the increased urokinase plasminogen activator (uPA)/urokinase-type plasminogen activator receptor…
  • Abstract Number: 1743 • 2012 ACR/ARHP Annual Meeting

    IL-5-Induced FasL+ Regulatory B Cells Are Inhibited by IL-4 and Cyclosporine

    Matthew W. Klinker1, Brian R. Alzua1, Tamra J. Reed2, David A. Fox3 and Steven K. Lundy4, 1Internal Medicine, University of Michigan, Ann Arbor, MI, 2Internal Medicine, Rheumatology, University of Michigan, Ann Arbor, MI, 3Rheumatology/Int Medicine, Univ of Michigan Med Ctr, Ann Arbor, MI, 4Internal Medicine-Rheumatology, University of Michigan, Ann Arbor, MI

    Background/Purpose: We previously identified a subset of regulatory B cells that express the apoptosis-inducing molecule Fas ligand (FasL), and reported that these B cells were…
  • Abstract Number: 1635 • 2012 ACR/ARHP Annual Meeting

    Polyarthritis Caused by TIARP (TNFAIP9) Deficiency Critically Dependent On Dysregulated STAT3, NF-κB Signaling and Cell Death in Macrophage

    Asuka Inoue1, Isao Matsumoto1, Naoto Umeda1, Yuki Tanaka1, Satoru Takahashi2 and Takayuki Sumida1, 1Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba city, Ibaraki, Japan, 2Department of Anatomy and Embryology, Faculty of Medicine, University of Tsukuba, Tsukuba city, Ibaraki, Japan

    Background/Purpose: TNFα-induced adipose-related protein (TIARP) is a six-transmembrane protein induced by TNFα and IL-6 in adipose tissue. Recently, we found that TIARP is dominantly expressed…
  • Abstract Number: 1522 • 2012 ACR/ARHP Annual Meeting

    Differential Response to Endoplasmic Reticulum Stress Between Alveolar Epithelial Cells and Lung Fibroblasts in Systemic Sclerosis

    Jun Liang1, Tanjina Akter2, Ilia Atanelishvili3, Richard M. Silver4 and Galina S. Bogatkevich2, 1Department of Rheumatology, Medical University of SC, Charleston, SC, 2Department of Rheumatology, Medical University of South Carolina,Charleston,USA, Charleston, SC, 3Division of Rheumatology & Immunology, Medical University of South Carolina,Charleston,USA, Charleston, SC, 4Rheumatology, Medical University of SC, Charleston, SC

    Background/Purpose: Interstitial lung disease is a prevalent and worrisome complication of systemic sclerosis (SSc), which is now the leading cause of death in SSc. There…
  • Abstract Number: 1494 • 2012 ACR/ARHP Annual Meeting

    CD40 Signaling Results in Microvascular Endothelial Dysfunction: A Possible Clue to the Pathogenesis of Scleroderma Vasculopathy

    Bashar Kahaleh1 and Yongqing Wang2, 1Medicine/Rheumatology, University of Toledo, Toledo, OH, 2Medicine, University of Toledo, Toledo, OH

    Background/Purpose: Increased expression of CD40 in SSc- Microvascular Endothelial Cells (MVEC) was noted on a gene expression array and increased concentrations of soluble CD40 ligand (sCD40L)…
  • Abstract Number: 1069 • 2012 ACR/ARHP Annual Meeting

    The Effects of TNF Stimulation On Control of Apoptosis in Neutrophils

    Direkrit Chiewchengchol1, Connie Lam1, Kate Roberts1, Helen Wright1, Huw Thomas1, Robert Moots2 and Steven Edwards1, 1Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom, 2University Hospital Aintree, Liverpool, United Kingdom

    Background/Purpose: TNF is a key regulator of immune function and plays a pivotal role in inflammatory conditions such as rheumatoid arthritis. Human neutrophils express and…
  • Abstract Number: 902 • 2012 ACR/ARHP Annual Meeting

    Activation of NF-Kb Via Poly(I:C)-Induced Monocyte-Derived Microparticles Decreases TRAIL-Induced Apoptosis of Rheumatoid Arthritis Synovial Fibroblasts

    Mojca Frank Bertoncelj1, Blaz Rozman2, Beat A. Michel3, Renate E. Gay1, David S. Pisetsky4, Oliver Distler5, Steffen Gay6 and Astrid Juengel7, 1Center of Experimental Rheumatology, University Hospital Zurich and Zurich Center of Integrative Human Physiology (ZIHP), Zurich, Switzerland, 2Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, 3Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 4Department of Medicine, Duke University Medical Center, Durham, NC, 5Department of Rheumatology and Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland, 6Rheumatology, Center of Experimental Rheumatology, University Hospital Zurich and Zurich Center of Integrative Human Physiology (ZIHP), Zurich, CH-8091, Switzerland, 7Center of Experimental Rheumatology, University Hospital Zurich, Zurich Schlieren, Switzerland

    Background/Purpose: Decreased sensitivity of rheumatoid arthritis (RA) synovial fibroblasts (SF) to apoptosis leads to synovial hyperplasia and destruction of joints in RA. Activation of NF-kB…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology